SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-062035
Filing Date
2019-12-27
Accepted
2019-12-27 16:54:19
Documents
1
Period of Report
2019-12-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4438
  Complete submission text file 0001209191-19-062035.txt   6159
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Issuer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address ARROWHEAD RESEARCH CORPORATION 201 SOUTH LAKE AVENUE, SUITE 703 PASADENA CA 91101
Business Address
Anzalone Christopher Richard (Reporting) CIK: 0001423029 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38042 | Film No.: 191314050